UTHR - United Therapeutics Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$636.83
DETAILS
HIGH:
$735.00
LOW:
$516.00
MEDIAN:
$635.00
CONSENSUS:
$636.83
UPSIDE:
12.03%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Dalio | 111,169 | $65.9M | 0.3% | +46,574 | INCREASED |
| Greenblatt | 80,387 | $47.7M | 0.1% | +369 | INCREASED |
| Cooperman | 20,000 | $11.9M | 0.0% | +18,800 | INCREASED |
| Wood | 10,600 | $6.3M | 0.0% | -175,564 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | M-Exempt | 10,000 | $117.76 | $1.2M |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 280 | $560.03 | $157K |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 160 | $566.42 | $91K |
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | SELL | 320 | $560.03 | $179K |
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | SELL | 920 | $562.01 | $517K |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 919 | $561.97 | $516K |
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | SELL | 2,081 | $564.10 | $1.2M |
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | SELL | 1,765 | $565.10 | $997K |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 1,760 | $562.98 | $991K |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | M-Exempt | 9,500 | $146.03 | $1.4M |
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | SELL | 40 | $557.85 | $22K |
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | SELL | 2,677 | $563.12 | $1.5M |
| 2026-05-21 | EDGEMOND JAMES | officer: CFO AND TREASURER | SELL | 2,197 | $566.12 | $1.2M |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 40 | $557.85 | $22K |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 2,242 | $563.77 | $1.3M |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 1,840 | $564.87 | $1.0M |
| 2026-05-21 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 2,259 | $566.02 | $1.3M |
| 2026-05-20 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 440 | $562.01 | $247K |
| 2026-05-20 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 552 | $570.38 | $315K |
| 2026-05-20 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | SELL | 376 | $571.41 | $215K |
| 2026-05-21 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | M-Exempt | 8,300 | $146.03 | $1.2M |
| 2026-05-21 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | M-Exempt | 8,000 | $146.03 | $1.2M |
| 2026-05-21 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | SELL | 200 | $559.99 | $112K |
| 2026-05-21 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | SELL | 2,178 | $561.99 | $1.2M |
| 2026-05-21 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | SELL | 1,251 | $565.20 | $707K |